Login to Your Account


Myelofibrosis

As sales of Incyte Corp.'s approved JAK inhibitor Jakafi (ruxolitinib) begin to pick up steam, a competing myelofibrosis candidate from Sanofi SA moved a step closer to market. more »


Our Habitat for All Things Science
Success Reported in Cloning Human Embryonic Stem Cells

Embryonic stem cells have been the subject of so many political fights that it's easy to forget they have also faced formidable scientific obstacles.

But they have. Human eggs, it turns out, are far more fragile than those of most other mammals – including those of other primates. And so, methods that have been used to clone mammals from Dolly the sheep to Snuppy, the cloned dog that was South Korean stem cell scientist Woo-Suk Hwang's only non-fraudulent claim to fame, have failed to produce therapeutically cloned human embryonic stem cells. Until now.

READ MORE »

Upcoming conferences
Royalty Financing for Biotech and Medical Device Companies: How to Determine Eligibility and Take Advantage of this Unique Financing Opportunity